Lanxess (LXS) Given a €52.00 Price Target at Independent Research

Independent Research set a €52.00 ($60.47) price objective on Lanxess (ETR:LXS) in a report published on Tuesday. The firm currently has a neutral rating on the stock.

LXS has been the subject of several other reports. HSBC set a €80.00 ($93.02) price target on Lanxess and gave the company a buy rating in a research note on Thursday, December 13th. Nord/LB set a €52.00 ($60.47) price target on Lanxess and gave the company a neutral rating in a research note on Friday, March 15th. Goldman Sachs Group set a €57.00 ($66.28) price target on Lanxess and gave the company a buy rating in a research note on Monday. UBS Group set a €53.00 ($61.63) price target on Lanxess and gave the company a neutral rating in a research note on Thursday, March 14th. Finally, DZ Bank reiterated a neutral rating on shares of Lanxess in a research report on Thursday, January 24th. Three analysts have rated the stock with a sell rating, twelve have assigned a hold rating and nine have assigned a buy rating to the stock. The stock has a consensus rating of Hold and an average target price of €61.83 ($71.89).

LXS opened at €50.52 ($58.74) on Tuesday. The firm has a market capitalization of $4.67 billion and a P/E ratio of 16.34. Lanxess has a 1 year low of €39.47 ($45.90) and a 1 year high of €72.60 ($84.42). The company has a quick ratio of 0.50, a current ratio of 2.54 and a debt-to-equity ratio of 75.18.

Lanxess Company Profile

LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.

Featured Article: Balance Sheet

Analyst Recommendations for Lanxess (ETR:LXS)

Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.